201 related articles for article (PubMed ID: 30883505)
1. Circulating Cell-Free DNA-Diagnostic and Prognostic Applications in Personalized Cancer Therapy.
Oellerich M; Schütz E; Beck J; Walson PD
Ther Drug Monit; 2019 Apr; 41(2):115-120. PubMed ID: 30883505
[TBL] [Abstract][Full Text] [Related]
2. Technical Advances in Circulating Cell-Free DNA Detection and Analysis for Personalized Medicine in Patients' Care.
Sorbini M; Carradori T; Togliatto GM; Vaisitti T; Deaglio S
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672514
[TBL] [Abstract][Full Text] [Related]
3. Circulating Tumor DNA as Biomarkers for Cancer Detection.
Han X; Wang J; Sun Y
Genomics Proteomics Bioinformatics; 2017 Apr; 15(2):59-72. PubMed ID: 28392479
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor DNA and its role in detection, prognosis and therapeutics of hepatocellular carcinoma.
Rashid S; Sun Y; Ali Khan Saddozai U; Hayyat S; Munir MU; Akbar MU; Khawar MB; Ren Z; Ji X; Ihsan Ullah Khan M
Chin J Cancer Res; 2024 Apr; 36(2):195-214. PubMed ID: 38751441
[TBL] [Abstract][Full Text] [Related]
5. Detection of Cell Types Contributing to Cancer From Circulating, Cell-Free Methylated DNA.
Barefoot ME; Loyfer N; Kiliti AJ; McDeed AP; Kaplan T; Wellstein A
Front Genet; 2021; 12():671057. PubMed ID: 34386036
[TBL] [Abstract][Full Text] [Related]
6. Clinical applications of liquid biopsies in gastrointestinal oncology.
Zhu J; Strickler JH
J Gastrointest Oncol; 2016 Oct; 7(5):675-686. PubMed ID: 27747082
[TBL] [Abstract][Full Text] [Related]
7. Personalized therapy guided by longitudinal liquid biopsies for treatment of leptomeningeal disease from lung adenocarcinoma: A case report.
Lai M; Mu T; Liu M; Hu Q; Li J; Huang T; Li Y; Chen S; Cai L
Oncol Lett; 2024 Jul; 28(1):299. PubMed ID: 38751754
[TBL] [Abstract][Full Text] [Related]
8. RNA Based Approaches to Profile Oncogenic Pathways From Low Quantity Samples to Drive Precision Oncology Strategies.
van de Stolpe A; Verhaegh W; Blay JY; Ma CX; Pauwels P; Pegram M; Prenen H; De Ruysscher D; Saba NF; Slovin SF; Willard-Gallo K; Husain H
Front Genet; 2020; 11():598118. PubMed ID: 33613616
[TBL] [Abstract][Full Text] [Related]
9. Clinical Applications of Liquid Biopsy in Non-Small Cell Lung Cancer Patients: Current Status and Recent Advances in Clinical Practice.
Park S; Lee JC; Choi CM
J Clin Med; 2021 May; 10(11):. PubMed ID: 34064038
[TBL] [Abstract][Full Text] [Related]
10. Cell-free nucleic acid patterns in disease prediction and monitoring-hype or hope?
Crigna AT; Samec M; Koklesova L; Liskova A; Giordano FA; Kubatka P; Golubnitschaja O
EPMA J; 2020 Dec; 11(4):603-627. PubMed ID: 33144898
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide cell-free DNA fragmentation in patients with cancer.
Cristiano S; Leal A; Phallen J; Fiksel J; Adleff V; Bruhm DC; Jensen SØ; Medina JE; Hruban C; White JR; Palsgrove DN; Niknafs N; Anagnostou V; Forde P; Naidoo J; Marrone K; Brahmer J; Woodward BD; Husain H; van Rooijen KL; Ørntoft MW; Madsen AH; van de Velde CJH; Verheij M; Cats A; Punt CJA; Vink GR; van Grieken NCT; Koopman M; Fijneman RJA; Johansen JS; Nielsen HJ; Meijer GA; Andersen CL; Scharpf RB; Velculescu VE
Nature; 2019 Jun; 570(7761):385-389. PubMed ID: 31142840
[TBL] [Abstract][Full Text] [Related]
12. Next-generation sequencing in liquid biopsy: cancer screening and early detection.
Chen M; Zhao H
Hum Genomics; 2019 Aug; 13(1):34. PubMed ID: 31370908
[TBL] [Abstract][Full Text] [Related]
13. Current Perspectives on Circulating Tumor DNA, Precision Medicine, and Personalized Clinical Management of Cancer.
Oliveira KCS; Ramos IB; Silva JMC; Barra WF; Riggins GJ; Palande V; Pinho CT; Frenkel-Morgenstern M; Santos SEB; Assumpcao PP; Burbano RR; Calcagno DQ
Mol Cancer Res; 2020 Apr; 18(4):517-528. PubMed ID: 31996469
[TBL] [Abstract][Full Text] [Related]
14. Life and death of circulating cell-free DNA.
Kustanovich A; Schwartz R; Peretz T; Grinshpun A
Cancer Biol Ther; 2019; 20(8):1057-1067. PubMed ID: 30990132
[TBL] [Abstract][Full Text] [Related]
15. Tissue and Cell-Free DNA-Based Epigenomic Approaches for Cancer Detection.
Leal A; Sidransky D; Brait M
Clin Chem; 2020 Jan; 66(1):105-116. PubMed ID: 31843869
[TBL] [Abstract][Full Text] [Related]
16. Dynamic Treatment Stratification Using ctDNA.
Vidal J; Taus A; Montagut C
Recent Results Cancer Res; 2020; 215():263-273. PubMed ID: 31605234
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor DNA as an early cancer detection tool.
Campos-Carrillo A; Weitzel JN; Sahoo P; Rockne R; Mokhnatkin JV; Murtaza M; Gray SW; Goetz L; Goel A; Schork N; Slavin TP
Pharmacol Ther; 2020 Mar; 207():107458. PubMed ID: 31863816
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis in Liquid Biopsy: From Biological Noise to Valuable Clinical Implications.
Chan HT; Chin YM; Nakamura Y; Low SK
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32823942
[TBL] [Abstract][Full Text] [Related]
20. Next Generation Sequencing for Gene Fusion Analysis in Lung Cancer: A Literature Review.
Bruno R; Fontanini G
Diagnostics (Basel); 2020 Jul; 10(8):. PubMed ID: 32726941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
